
HIV prevention options expanded in the US
The US Food and Drug Administration (FDA) has approved a long-acting HIV prevention medication for the first time. The drug Developed by ViiV Healthcare, the medicine is long-acting cabotegravir injected once every two months. The FDA has approved the medicine for use by adults and adolescents weighing… Read More















